8-K - AbbVie Inc. (0001551152) (Filer)
Published . Updated .
Filed: 2026-10-15 AccNo: 0001104659-26-116227 Size: 276 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Directly affected
- ABBV AbbVie
Named in this report.
Indirectly affected
- SPY SPDR S&P 500
The broad U.S. stock market
- TLT iShares 20+ Year Treasury Bond
Long-term U.S. government bonds
- QQQ Invesco QQQ
Large technology stocks
- GLD SPDR Gold Shares
Gold can move with the broad market
Price reaction, T-5 to T+3
Filed: 2026-10-15 AccNo: 0001104659-26-116227 Size: 276 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Source: sec-edgar
AbbVie (ABBV) since this story, compared with the market
Since the first closing price after “8-K - AbbVie Inc. (0001551152) (Filer),” AbbVie (ABBV) is -0.94%. The S&P 500 fund (SPY) is +0.43% over the same days, a -1.37% difference versus the market.
| Company | When | Move | Status |
|---|---|---|---|
| AbbVie (ABBV) | that day | +0.75% | final price |
| AbbVie (ABBV) | the next day | -0.25% | final price |
| AbbVie (ABBV) | two days later | +1.65% | still updating |
| AbbVie (ABBV) | three days earlier | -3.21% | final price |
| AbbVie (ABBV) | five days earlier | -2.45% | final price |
| GLD | that day | -0.17% | final price |
| GLD | the next day | -0.79% | final price |
| GLD | two days later | -1.15% | still updating |
| GLD | three days earlier | -0.27% | final price |
| GLD | five days earlier | +0.50% | final price |
| QQQ | that day | -2.52% | final price |
| QQQ | the next day | -1.36% | final price |
| QQQ | two days later | -1.67% | still updating |
| QQQ | three days earlier | +2.12% | final price |
| QQQ | five days earlier | +3.17% | final price |
| SPY | that day | -1.09% | final price |
| SPY | the next day | -0.67% | final price |
| SPY | two days later | -0.49% | still updating |
| SPY | three days earlier | +0.81% | final price |
| SPY | five days earlier | +0.87% | final price |
| TLT | that day | +0.06% | final price |
| TLT | the next day | -0.66% | final price |
| TLT | two days later | +0.16% | still updating |
| TLT | three days earlier | -2.05% | final price |
| TLT | five days earlier | -2.54% | final price |
Filings that name AbbVie (ABBV) around 15 Oct 2026
- Pete Sessions sell AbbVie (ABBV) ($15,001 - $50,000). That is 31 days before publication, inside 60 days. The filing is listed beside the story “8-K - AbbVie Inc. (0001551152) (Filer).”
- Rohit Khanna sell AbbVie (ABBV) ($1,001 - $15,000). That is 41 days before publication, inside 60 days. The filing is listed beside the story “8-K - AbbVie Inc. (0001551152) (Filer).”
Public disclosure filings, not a recommendation. The filing link is the source document. News use of these reports still sits under 5 U.S.C. § 13107(c).
Who is named in “8-K - AbbVie Inc. (0001551152) (Filer)”
Companies carried with this story
- ABBV AbbVie
AbbVie (ABBV) is linked, with no stored direction, high confidence in the 15 Oct 2026 story “8-K - AbbVie Inc. (0001551152) (Filer).” Reason on file: SEC 8-K filing -> direct issuer disclosure -> ABBV
How “8-K - AbbVie Inc. (0001551152) (Filer)” reaches AbbVie (ABBV)
“8-K - AbbVie Inc. (0001551152) (Filer)” (15 Oct 2026) reaches AbbVie (ABBV) through this story.
AbbVie (ABBV) is on the page because SEC 8-K filing -> direct issuer disclosure -> ABBV
Price levels for AbbVie (ABBV)
ABBV traded between 257.86 and 291.42 across 20 sessions. The latest close on file is 282.72.
A simple score for AbbVie (ABBV)
13 out of 100Price not final
“8-K - AbbVie Inc. (0001551152) (Filer)” scores 13 out of 100. The score uses 1 sources, a +0.42% difference versus the S&P 500 (SPY), and 1 linked companies. The price is not final yet.